Skip to main content
. 2021 Mar 23;12(10):1549–1557. doi: 10.1111/1759-7714.13939

FIGURE 6.

FIGURE 6

Decreasing the level of protein kinase, DNA‐activated, catalytic polypeptide (PRKDC) can reverse miRNA‐218‐5p‐inhibitor radiation‐resistant lung cancer cell apoptosis. (a) An EdU DNA cell proliferation test was used to evaluate changes in the number of cells undergoing DNA synthesis after cotransfection of the miRNA‐218‐5p‐inhibitor and si‐PRKDC. (b) Flow cytometry was used to evaluate changes in the apoptosis rates after cotransfection of the miRNA‐218‐5p‐inhibitor and si‐PRKDC. *p < 0.05; **p < 0.01